AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of $23.95 billion and leading positions in sales of gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection products. In the United States, AstraZeneca is a $10.77 billion healthcare business with more than 12,000 employees. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.
For more information about AstraZeneca, please visit: www.astrazeneca-us.com

Healthways provides total population health management solutions aimed at lowering costs and improving quality of care for health plans the government and employers. We deliver integrated health and care support programs, including health risk screening and support, condition and disease management and high-risk care management to more than 2 million people. Through innovation, collaboration and a relentless pursuit for flawless execution, we have returned more than $1 billion in healthcare savings to our customers. For more information, visit www.healthways.com.

Reckitt Benckiser Pharmaceuticals is at the forefront providing educational resources and treatment options to health plans, physicians, and patients dealing with the chronic relapsing disease of opioid dependence. Reckitt Benckiser national account managers will be available to discuss the public health, reimbursement and scientific information for opioid dependence and answer your questions regarding treatment and the care continuum.
Products: Suboxone® and Subutex®